Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (321-330 of 436) with videos related to

Pageof 44
Sort By:
Seminars in Arthritis and Rheumatism|August 16, 2021
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PFYing-Ying Leung, Ana-Maria Orbai, Pil Hojgaard, et al.
Rheumatology and Therapy|August 21, 2020
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 WeeksHelena Marzo-Ortega, Philip J Mease, Proton Rahman, et al.
Seminars in Arthritis and Rheumatism|September 14, 2020
Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic reviewYing-Ying Leung, Richard Holland, Ashish J Mathew, et al.
The Journal of Rheumatology|July 17, 2020
Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal StudiesUta Kiltz, James Cheng-Chung Wei, Désirée van der Heijde, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 5, 2014
Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis painRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Journal of Clinical Epidemiology|March 4, 2014
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0Maarten Boers, John R Kirwan, George Wells, et al.
The Journal of Rheumatology|August 13, 2009
Multiple computer-based methods of measuring joint space width can discriminate between treatment arms in the COBRA trial -- Update of an ongoing OMERACT projectJohn T Sharp, Jane Angwin, Maarten Boers, et al.
JAMA Dermatology|January 24, 2024
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis: A Systematic ReviewLourdes M Pérez-Chada, Zachary H Hopkins, Deepak M W Balak, et al.
Arthritis Care & Research|March 23, 2012
Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhoodArnd Heiligenhaus, Ivan Foeldvari, Clive Edelsten, et al.
The Journal of Rheumatology|April 16, 2021
Test-retest Reliability for HAQ-DI and SF-36 PF for the Measurement of Physical Function in Psoriatic ArthritisYing Ying Leung, William Tillett, Pil Hojgaard, et al.
Pageof 44

Showing results (321-330 of 436) with videos related to

Sort By:
Pageof 44
Seminars in Arthritis and Rheumatism|August 16, 2021
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PFYing-Ying Leung, Ana-Maria Orbai, Pil Hojgaard, et al.
Rheumatology and Therapy|August 21, 2020
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 WeeksHelena Marzo-Ortega, Philip J Mease, Proton Rahman, et al.
Seminars in Arthritis and Rheumatism|September 14, 2020
Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic reviewYing-Ying Leung, Richard Holland, Ashish J Mathew, et al.
The Journal of Rheumatology|July 17, 2020
Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal StudiesUta Kiltz, James Cheng-Chung Wei, Désirée van der Heijde, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 5, 2014
Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis painRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Journal of Clinical Epidemiology|March 4, 2014
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0Maarten Boers, John R Kirwan, George Wells, et al.
The Journal of Rheumatology|August 13, 2009
Multiple computer-based methods of measuring joint space width can discriminate between treatment arms in the COBRA trial -- Update of an ongoing OMERACT projectJohn T Sharp, Jane Angwin, Maarten Boers, et al.
JAMA Dermatology|January 24, 2024
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis: A Systematic ReviewLourdes M Pérez-Chada, Zachary H Hopkins, Deepak M W Balak, et al.
Arthritis Care & Research|March 23, 2012
Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhoodArnd Heiligenhaus, Ivan Foeldvari, Clive Edelsten, et al.
The Journal of Rheumatology|April 16, 2021
Test-retest Reliability for HAQ-DI and SF-36 PF for the Measurement of Physical Function in Psoriatic ArthritisYing Ying Leung, William Tillett, Pil Hojgaard, et al.
Pageof 44